Tissue-specific effects of loss of estrogen during menopause and aging

Frontiers in Endocrinology

Volumn 3, Issue FEB, 2012, Pages

  Wend, Korinna ^a   Wend, Peter ^a   Krum, Susan A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Estrogen; SERM; Tissue specificity

Indexed keywords

EID: 84873451022     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00019     Document Type: Review

References (190)

1. Albright, F., Bloomberg, E., and Smith, P. H. (1940). Postmenopausal osteoporosis. Trans. Assoc. Am. Physicians 55, 298-305.
2. Arnal, J. F., Scarabin, P. Y., Tremol-lieres, F., Laurell, H., and Gourdy, P. (2007). Estrogens in vascular biology and disease: where do we stand today? Curr. Opin. Lipidol. 18, 554-560.
3. Arowojolu, A. O., Gallo, M. F., Lopez, L. M., Grimes, D. A., and Garner, S. E. (2009). Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst. Rev. 3, CD004425.
4. Ashcroft, G. S., Dodsworth, J., Van Box-tel, E., Tarnuzzer, R. W., Horan, M. A., Schultz, G. S., and Ferguson, M. W. (1997). Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat. Med. 3, 1209-1215.
5. Ashcroft, G. S., Mills, S. J., Lei, K., Gibbons, L., Jeong, M. J., Taniguchi, M., Burow, M., Horan, M. A., Wahl, S. M., and Nakayama, T. (2003). Estrogen modulates cutaneous wound healing by down-regulating macrophage migration inhibitory factor. J. Clin. Invest. 111, 1309-1318.
6. Barone, I., Brusco, L., and Fuqua, S. A. (2010). Estrogen receptor mutations and changes in downstream gene expression and signaling. Clin. Cancer Res. 16, 2702-2708.
7. Barros, R. P., Machado, U. F., Warner, M., and Gustafsson, J. A. (2006). Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc. Natl. Acad. Sci. U.S.A. 103, 1605-1608.
8. Baumann, L. (2005). A dermatologist's opinion on hormone therapy and skin aging. Fertil. Steril. 84, 289-290; discussion 295.
9. Bertram, L., Mcqueen, M. B., Mullin, K., Blacker, D., and Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23.
10. Blennow, K., Hesse, C., and Fred-man, P. (1994). Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease. Neuroreport 5, 2534-2536.
11. Bord, S., Ireland, D. C., Beavan, S. R., and Compston, J. E. (2003). The effects of estrogen on osteoprote-gerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32, 136-141.
12. Brinton, R. D. (2005). Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann. N. Y. Acad. Sci. 1052, 57-74.
13. Burek, M., Arias-Loza, P. A., Roewer, N., and Forster, C. Y. (2010). Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler. Thromb. Vasc. Biol. 30, 298-304.
14. Cabilla, J. P., Diaz Mdel, C., Machiavelli, L. I., Poliandri, A. H., Quinteros, F. A., Lasaga, M., and Duvilanski, B. H. (2006). 17 beta-estradiol modifies nitric oxide-sensitive guanylyl cyclase expression and down-regulates its activity in rat anterior pituitary gland. Endocrinology 147, 4311-4318.
15. Canaris, G. J., Manowitz, N. R., Mayor, G., and Ridgway, E. C. (2000). The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526-534.
16. Candore, G., Balistreri, C. R., Grimaldi, M. P., Vasto, S., Listi, F., Chiappelli, M., Licastro, F., Lio, D., and Caruso, C. (2006). Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. Ann. N. Y. Acad. Sci. 1089, 472-486.
17. Carr, M. C. (2003). The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 88, 2404-2411.
18. Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hes-termann, E. V., Geistlinger, T. R., Fox, E. A., Silver, P. A., and Brown, M. (2005). Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43.
19. Carroll, P. V., Christ, E. R., Bengtsson, B. A., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., Sonksen, P. H., Tanaka, T., and Thorne, M. (1998). Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 83, 382-395.
20. Chen, Y. H., Lee, M. J., Chang, H. H., Hung, P. F., and Kao, Y. H. (2006). 17 beta-estradiol stimulates resistin gene expression in 3T3-L1 adipocytes via the estrogen receptor, extracellularly regulated kinase, and CCAAT/enhancer binding protein-alpha pathways. Endocrinology 147, 4496-4504.
21. Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., and Shaul, P. W. (1999). Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401-406.
22. Chiechi, L. M., Ferreri, R., Granieri, M., Bianco, G., Berardesca, C., and Loizzi, P. (1997). Climacteric syndrome and body-weight. Clin. Exp. Obstet. Gynecol. 24, 163-166.
23. Chung, J. H., Kang, S., Varani, J., Lin, J., Fisher, G. J., and Voorhees, J. J. (2000). Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J. Invest. Dermatol. 115, 177-182.
24. Collins, P., Mosca, L., Geiger, M. J., Grady, D., Kornitzer, M., Amewou-Atisso, M. G., Effron, M. B., Dowsett, S. A., Barrett-Connor, E., and Wenger, N. K. (2009). Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the ralox-ifene use for the heart trial: results of subgroup analyses by age and other factors. Circulation 119, 922-930.
25. Cooke, P. S., and Naaz, A. (2004). Role of estrogens in adipocyte development and function. Exp. Biol. Med. 229, 1127-1135.
26. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
27. Craig, M. C., and Murphy,D. G. (2007). Estrogen: effects on normal brain function and neuropsychiatric disorders. Climacteric 10(Suppl. 2), 97-104.
28. Cummings, S. R., Ensrud, K., Delmas, P. D., Lacroix, A. Z., Vukicevic, S., Reid,D. M., Goldstein, S., Sriram, U., Lee, A., Thompson, J., Armstrong, R. A., Thompson, D. D., Powles, T., Zanchetta, J., Kendler, D., Neven, P., and Eastell, R. (2010). Laso-foxifene in postmenopausal women with osteoporosis. N. Engl. J. Med. 362, 686-696.
29. Cutter, W. J., Craig, M., Norbury, R., Robertson, D. M., Whitehead, M., and Murphy, D. G. (2003). In vivo effects of estrogen on human brain. Ann. N. Y. Acad. Sci. 1007, 79-88.
30. Delmas, P. D., Bjarnason, N. H., Mitlak, B. H., Ravoux, A. C., Shah, A. S., Huster, W. J., Draper, M., and Christiansen, C. (1997). Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337, 1641-1647.
31. Deschamps, A. M., Murphy, E., and Sun, J. (2010). Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc. Med. 20, 73-78.
32. Dieli-Conwright, C. M., Spektor, T. M., Rice, J. C., and Todd Schroeder, E. (2009). Oestradiol and SERM treatments influence oestrogen receptor coregulator gene expression in human skeletal muscle cells. Acta Physiol. (Oxf.) 197, 187-196.
33. Dieudonne, M. N., Sammari, A., Dos Santos, E., Leneveu, M. C., Giudi-celli, Y., and Pecquery, R. (2006). Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J. Steroid Biochem. Mol. Biol. 99, 189-196.
34. Donahue, C. P., Kosik, K. S., and Shors, T. J. (2006). Growth hormone is produced within the hippocampus where it responds to age, sex, and stress. Proc. Natl. Acad. Sci. U.S.A. 103, 6031-6036.
35. Dos Santos, E. G., Dieudonne, M. N., Pecquery, R., Le Moal, V., Giu-dicelli, Y., and Lacasa, D. (2002). Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology 143, 930-940.
36. Eichenbaum, H.,Otto, T., and Cohen,N. J. (1992). The hippocampus-what does it do? Behav. Neural Biol. 57, 2-36.
37. Emmerson, E., Campbell, L., Ashcroft, G. S., and Hardman, M. J. (2010). The phytoestrogen genistein promotes wound healing by multiple independent mechanisms. Mol. Cell. Endocrinol. 321, 184-193.
38. Emmerson, E., and Hardman, M. J. (2011). The role of estrogen deficiency in skin ageing and wound healing. Biogerontology doi:10.1007/s10522-011-9322-y.
39. Engeli, S., Bohnke, J., Feldpausch, M., Gorzelniak, K., Heintze, U., Janke, J., Luft,F.C.,and Sharma,A.M. (2004). Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes. Res. 12, 9-17.
40. Enna, S. J., Samirajski, T., and Beer, B. (1987). Brain Neurotransmitters and Receptors in Aging and Age-related Disorders. New York: Raven Press.
41. Enns, D. L., and Tiidus, P. M. (2010). The influence of estrogen on skeletal muscle: sex matters. Sports Med. 40, 41-58.
42. Fabris, B., Candido, R., Bortoletto, M., Toffoli, B., Bernardi, S., Stebel, M., Bardelli, M., Zentilin, L., Giacca, M., and Carretta, R. (2011). Stimulation of cardiac apoptosis in ovariectomized hypertensive rats: potential role of the renin-angiotensin system. J. Hypertens. 29, 273-281.
43. Fazliana, M., Wan Nazaimoon, W. M., Gu, H. F., and Ostenson, C. G. (2009). Labisia pumila extract regulates body weight and adipokines in ovariectomized rats. Maturitas 62, 91-97.
44. -/- mouse heart. Proc. Natl. Acad. Sci. U.S.A. 101, 14234-14239.
45. Freedman, R. R. (2005). Pathophysiology and treatment of menopausal hot flashes. Semin. Reprod. Med. 23, 117-125.
46. Gibbs, R. B. (1998). Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 151, 289-302.
47. Gillies, G. E., and McArthur, S. (2010). Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: a contribution to sex-specific neuroprotection by estrogens. Horm. Behav. 57, 23-34.
48. Graham, B. H., Waymire, K. G., Cot-trell, B., Trounce, I. A., Macgregor, G. R., and Wallace, D. C. (1997). A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat. Genet. 16, 226-234.
49. Grohe, C., Kahlert, S., Lobbert, K., Stim-pel, M., Karas, R. H., Vetter, H., and Neyses, L. (1997). Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett. 416, 107-112.
50. Gui, Y., Silha, J. V., and Murphy, L. J. (2004). Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res. 12, 1481-1491.
51. Gupta, P., Harte, A. L., Da Silva, N. F., Khan, H., Barnett, A. H., Kumar, S., Sturdee, D. W., and Mcternan, P. G. (2007). Expression of calcitonin generelated peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status. Menopause 14, 1031-1038.
52. Haczynski, J., Tarkowski, R., Jarzabek, K., Slomczynska, M., Wolczynski, S., Magoffin, D. A., Jakowicki, J. A., and Jakimiuk, A. J. (2002). Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int. J. Mol. Med. 10, 149-153.
53. Hagstad, A., and Janson, P. O. (1986). The epidemiology of climacteric symptoms. Acta Obstet. Gynecol. Scand. Suppl. 134, 59-65.
54. Hall, E., Frey, B. N., and Soares, C. N. (2011). Non-hormonaltreatment strategies for vasomotor symptoms: a critical review. Drugs 71, 287-304.
55. Hayes, D. F., Skaar, T. C., Rae, J. M., Henry, N. L., Nguyen, A. T., Stearns, V., Li, L., Philips, S., Desta, Z., and Flockhart, D. A. (2010). Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results. Clin. Pharmacol. Ther. 88, 626-629.
56. Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., and Cooke, P. S. (2000). Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U.S.A. 97, 12729-12734.
57. Henderson, V. W. (2006). Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138, 1031-1039.
58. Henry, J. M., Filburn, C. R., Joseph, J. A., and Roth, G. S. (1986). Effect of aging on striatal dopamine receptor subtypes in Wistar rats. Neurobiol. Aging 7, 357-361.
59. Hentges, S., Pastorcic, M., De, A., Boy-adjieva, N., and Sarkar, D. K. (2000). Opposing actions of two transforming growth factor-beta isoforms on pituitary lactotropic cell proliferation. Endocrinology 141, 1528-1535.
60. Hill, R. A., and Boon, W. C. (2009). Estrogens, brain, and behavior: lessons from knockout mouse models. Semin. Reprod. Med. 27, 218-228.
61. Hou, Y., Wei, H., Luo, Y., and Liu, G. (2010). Modulating expression of brain heat shock proteins by estrogen in ovariectomized mice model of aging. Exp. Gerontol. 45, 323-330.
62. Huang, S. W., Seow, K. M., Ho, L. T., Chien, Y., Chung, D. Y., Chang, C. L., Lai, Y. H., Hwang, J. L., and Juan, C. C. (2005). Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett. 579, 449-454.
63. Hughes, S. V., Robinson, E., Bland, R., Lewis, H. M., Stewart, P. M., and Hewison, M. (1997). 1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes. Endocrinology 138, 3711-3718.
64. Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B., and Vittinghoff, E. (1998). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280, 605-613.
65. Hutton, J. D., Jacobs, H. S., Murray, M. A., and James, V. H. (1978). Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1, 678-681.
66. Iruthayanathan, M., Zhou, Y. H., and Childs, G. V. (2005). Dehy-droepiandrosterone restoration of growth hormone gene expression in aging female rats, in vivo and in vitro: evidence for actions via estrogen receptors. Endocrinology 146, 5176-5187.
67. Ishunina, T. A., Fischer, D. F., and Swaab, D. F. (2007). Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol. Aging 28, 1670-1681.
68. Ishunina, T. A., and Swaab, D. F. (2008). Estrogen receptor-alpha splice variants in the human brain. Gynecol. Endocrinol. 24, 93-98.
69. Jacobsen, D. E., Samson, M. M., Van Der Schouw, Y. T., Grobbee, D. E., and Verhaar, H. J. (2008). Efficacy of tibolone and raloxifene for the maintenance of skeletal muscle strength, bone mineral density, balance, body composition, cognitive function, mood/depression, anxiety and quality of life/well-being in late postmenopausal women >/= 70 years: study design of a randomized, double-blind, double-dummy, placebo-controlled, single-center trial. Trials 9, 32.
70. Jee, S. H., Lee, S. Y., Chiu, H. C., Chang, C. C., and Chen, T. J. (1994). Effects of estrogen and estrogen receptor in normal human melanocytes. Biochem. Biophys. Res. Commun. 199, 1407-1412.
71. Johnson, B. D., Zheng, W., Korach, K. S., Scheuer, T., Catterall, W. A., and Rubanyi, G. M. (1997). Increased expression of the cardiac L-type calcium channel in estrogen receptor-deficient mice. J. Gen. Physiol. 110, 135-140.
72. Kahlert, S., Grohe, C., Karas, R. H., Lob-bert, K., Neyses, L., and Vetter, H. (1997). Effects of estrogen on skeletal myoblast growth. Biochem. Bio-phys. Res. Commun. 232, 373-378.
73. Khosla, S., Melton, L. J. III, and Riggs, B. L. (2011). The unitary model for estrogen deficiency, and the patho-genesis of osteoporosis: is a revision needed? J. Bone Miner. Res. 26, 441-451.
74. Kislauskis, E., Bullock, B., Mcneil, S., and Dobner, P. R. (1988). The rat gene encoding neurotensin and neuromedin N. Structure, tissue-specific expression, and evolution of exon sequences. J. Biol. Chem. 263, 4963-4968.
75. Klouche, M. (2006). Estrogens in human vascular diseases. Ann. N. Y. Acad. Sci. 1089, 431-443.
76. Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R., Seckl, J. R., and Mullins, J. J. (1997). 11Beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. U.S.A. 94, 14924-14929.
77. Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., Digregorio, G. B., Katzenellenbogen, J. A., Katzenellen-bogen, B. S., Roberson, P. K., Wein-stein, R. S., Jilka, R. L., and Manola-gas, S. C. (2001). Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104, 719-730.
78. Kousteni, S., Chen, J. R., Bellido, T., Han, L., Ali, A. A., O'Brien, C. A., Plotkin, L., Fu, Q., Mancino, A. T., Wen, Y., Vertino, A. M., Powers, C. C., Stewart,S. A., Ebert, R., Parfitt, A. M., Weinstein, R. S., Jilka, R. L., and Manolagas, S. C. (2002). Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 298, 843-846.
79. Kremer, M., Judd, J., Rifkin, B., Ausz-mann, J., and Oursler, M. J. (1995). Estrogen modulation of osteoclast lysosomal enzyme secretion. J. Cell. Biochem. 57, 271-279.
80. Kronenberg, F., and Fugh-Berman, A. (2002). Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann. Intern. Med. 137, 805-813.
81. Krum, S. A. (2011). Direct transcriptional targets of sex steroid hormones in bone. J. Cell. Biochem. 112, 401-408.
82. Krum, S. A., Chang, J., Miranda-Carboni, G., and Wang, C. Y. (2010). Novel functions for NFkappaB: inhibition of bone formation. Nat. Rev. Rheumatol. 6, 607-611.
83. Krum, S. A., Miranda-Carboni, G. A., Hauschka, P. V., Carroll, J. S., Lane, T. F., Freedman, L. P., and Brown, M. (2008a). Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27, 535-545.
84. Krum, S. A., Miranda-Carboni, G. A., Lupien, M., Eeckhoute, J., Carroll, J. S., and Brown, M. (2008b). Unique ER{alpha} cistromes control cell type-specific gene regulation. Mol. Endocrinol. 22, 2393-2406.
85. Kusminski, C. M., Mcternan, P. G., and Kumar, S. (2005). Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci. 109, 243-256.
86. Lakoski, S. G., Brosnihan, B., and Herrington, D. M. (2005). Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the estrogen replacement on progression of coronary artery atherosclerosis (ERA) trial. Am. Heart J. 150, 907-911.
87. Lamberts, S. W., Van Den Beld, A. W., and Van Der Lely, A. J. (1997). The endocrinology of aging. Science 278, 419-424
88. Langan, E. A., Ramot, Y., Hanning, A., Poeggeler, B., Biro, T., Gas-par, E., Funk, W., Griffiths, C. E., and Paus, R. (2010). Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br. J. Dermatol. 162, 1127-1131.
89. Lemoine, S., Granier, P., Tiffoche, C., Rannou-Bekono, F., Thieulant, M. L., and Delamarche, P. (2003). Estrogen receptor alpha mRNA in human skeletal muscles. Med. Sci. Sports Exerc. 35, 439-443.
90. Levin, E. R. (2005). Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19, 1951-1959.
91. Li, Y., Jiang, C., Wang, X., Zhang, Y., Shibahara, S., and Takahashi, K. (2007). Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues. Peptides 28, 1129-1143.
92. Liu, D., Deschamps, A., Korach, K. S., and Murphy, E. (2008). Estrogen-enhanced gene expression of lipoprotein lipase in heart is antagonized by progesterone. Endocrinology 149, 711-716.
93. Loeser, A. A. (1937). The resorption and action of follicular hormone rubbed into the skin. J. Obstet. Gynaecol. Br. Emp. 44, 710-714.
94. Loughna, P. T., Mason, P., Bayol, S., and Brownson, C. (2000). The LIM-domain protein FHL1 (SLIM 1) exhibits functional regulation in skeletal muscle. Mol. Cell Biol. Res. Commun. 3, 136-140.
95. Lowe, D. A., Baltgalvis, K. A., and Greising, S. M. (2010). Mechanisms behind estrogen's beneficial effect on muscle strength in females. Exerc. Sport Sci. Rev. 38, 61-67.
96. Luine, V. N., Renner, K. J., Heady, S., and Jones, K. J. (1986). Age and sex-dependent decreases in ChAT in basal forebrain nuclei. Neurobiol. Aging 7, 193-198.
97. Machinal, F., Dieudonne, M. N., Len-eveu, M. C., Pecquery, R., and Giu-dicelli, Y. (1999). In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 140, 1567-1574.
98. Macotela, Y., Boucher, J., Tran, T. T., and Kahn, C. R. (2009). Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58, 803-812.
99. Martin-Millan, M., Almeida, M., Ambrogini, E., Han, L., Zhao, H., Weinstein, R. S., Jilka, R. L., O'Brien, C A., and Manolagas, S. C. (2010). The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 24, 323-334.
100. Martinoli, M. G., Ouellet, J., Rheaume, E., and Pelletier, G. (1991). Growth hormone and somatostatin gene expression in adult and aging rats as measured by quantitative in situ hybridization. Neuroendocrinology 54, 607-615.
101. Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., and Flier, J. S. (2001). A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170.
102. McEwen, B. S. (2001). Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol. 91, 2785-2801.
103. McMillan, P. J., Singer, C. A., and Dorsa, D M. (1996). The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J. Neurosci. 16, 1860-1865.
104. Mesco, E. R., Joseph, J. A., Blake, M. J., and Roth, G. S. (1991). Loss of D2 receptors during aging is partially due to decreased levels of mRNA. Brain Res. 545, 355-357.
105. Miranda-Carboni, G. A., Guemes, M., Bailey, S., Anaya, E., Corselli, M., Peault, B., and Krum, S. A. (2011). gata4 regulates estrogen receptor-{alpha}-mediated osteoblast transcription. Mol. Endocrinol. 7, 1126-1136.
106. Misiti, S., Schomburg, L., Yen, P. M., and Chin, W. W. (1998). Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 139, 2493-2500.
107. Misso, M. L., Jang, C., Adams, J., Tran, J., Murata, Y., Bell, R., Boon, W. C., Simpson, E. R., and Davis, S. R. (2005a). Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause 12, 210-215.
108. Misso, M. L., Jang, C., Adams, J., Tran, J., Murata, Y., Bell, R., Boon, W. C., Simpson, E. R., and Davis, S. R. (2005b). Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas 51, 299-306.
109. Mohamed, M. K., and Abdel-Rahman, A. A. (2000). Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats. Eur. J. Endocrinol. 142, 307-314.
110. Moran, A. L., Nelson, S. A., Landisch, R. M., Warren, G. L., and Lowe, D. A. (2007). Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice. J. Appl. Physiol. 102, 1387-1393.
111. Morello, K. C., Wurz, G. T., and Degre-gorio, M. W. (2002). SERMs: current status and future trends. Crit. Rev. Oncol. Hematol. 43, 63-76.
112. Morton, N. M., Holmes, M. C., Fievet, C., Staels, B., Tailleux, A., Mullins, J. J., and Seckl, J. R. (2001). Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehy-drogenase type 1 null mice. J. Biol. Chem. 276, 41293-41300.
113. Murase, Y., Kobayashi, J., Nohara, A., Asano, A., Yamaaki, N., Suzuki, K., Sato, H., and Mabuchi, H. (2006). Raloxifene promotes adipocyte differentiation of 3T3-L1 cells. Eur. J. Pharmacol. 538, 1-4.
114. Naftolin, F., Mor, G., Horvath, T. L., Luquin, S., Fajer,A. B., Kohen, F., and Garcia-Segura, L. M. (1996). Synaptic remodeling in the arcuate nucleus during the estrous cycle is induced by estrogen and precedes the preovulatory gonadotropin surge. Endocrinology 137, 5576-5580.
115. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P., and Kato, S. (2007). Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823.
116. Nelson, H. D. (2004). Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 291, 1610-1620.
117. Nishizawa, H., Shimomura, I., Kishida, K., Maeda, N., Kuriyama, H., Nagaretani, H., Matsuda, M., Kondo, H., Furuyama, N., Kihara, S., Nakamura, T., Tochino, Y., Funahashi, T., and Matsuzawa, Y. (2002). Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51, 2734-2741.
118. O'Boyle, K. M., and Waddington, J. L. (1984). Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol. Eur. J. Pharmacol. 105, 171-174.
119. Ohlsson, C., Hellberg, N., Parini, P., Vidal, O., Bohlooly, Y. M., Rudling, M., Lindberg, M. K., Warner, M., Angelin, B., and Gustafsson, J. A. (2000). Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem. Biophys. Res. Commun. 278, 640-645.
120. Olmos, G., Naftolin, F., Perez, J., Tranque, P. A., and Garcia-Segura, L. M. (1989). Synaptic remodeling in the rat arcuate nucleus during the estrous cycle. Neuroscience 32, 663-667.
121. O'Malley, B. (2008). The year in basic science: nuclear receptors and coregulators. Mol. Endocrinol. 22, 2751-2758.
122. Otsuki, M., Gao, H., Dahlman-Wright, K., Ohlsson, C., Eguchi, N., Urade, Y., and Gustafsson, J. A. (2003). Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Mol. Endocrinol. 17, 1844-1855.
123. Pantschenko, A. G., Zhang, W., Nahounou, M., Mccarthy, M. B., Stover, M. L., Lichtler, A. C., Clark, S. H., and Gronowicz, G. A. (2005). Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. J. Bone Miner. Res. 20, 1414-1429.
124. Park, Y. W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., and Heymsfield, S. B. (2003). The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 163, 427-436.
125. Pedersen, S. B., Borglum, J. D., Moller-Pedersen, T., and Richelsen, B. (1992). Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol. Cell. Endocrinol. 85, 13-19.
126. Pedraza-Alva, G., Zingg, J. M., Donda, A., and Perez-Martinez, L. (2009). Estrogen receptor regulates MyoD gene expression by preventing AP-1-mediated repression. Biochem. Biophys. Res. Commun. 389, 360-365.
127. Perlman, W. R., Matsumoto, M., Beltaifa, S., Hyde, T. M., Saunders, R. C., Webster, M. J., Rubinow, D. R., Kleinman, J. E., and Weickert, C. S. (2005). Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex. Neu-roscience 134, 81-95.
128. Poirier, J. (1996). Apolipoprotein E in the brain and its role in Alzheimer's disease. J. Psychiatry Neurosci. 21, 128-134.
129. Pollanen, E., Fey, V., Tormakangas, T., Ronkainen, P. H., Taaffe, D. R., Takala, T., Koskinen, S., Cheng, S., Puolakka, J., Kujala, U. M., Suominen, H., Sipila, S., and Kova-nen, V. (2010). Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle. Age (Omaha) 32, 347-363.
130. Pollanen, E., Sipila, S., Alen, M., Ronkainen, P. H., Ankarberg-Lindgren, C., Puolakka, J., Suominen, H., Hamalainen, E., Turpeinen, U., Konttinen, Y. T., and Kovanen, V. (2011). Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre-and post-menopausal women. Aging Cell 10, 650-660.
131. Post, W. S., Goldschmidt-Clermont, P. J., Wilhide, C. C., Heldman, A. W., Sussman, M. S., Ouyang, P., Mil-liken, E. E., and Issa, J. P. (1999). Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43, 985-991.
132. Powles, T. J. (2002). Anti-oestrogenic prevention of breast cancer-the make or breakpoint. Nat. Rev. Cancer 2, 787-794.
133. Price, D. L. (1986). New perspectives on Alzheimer's disease. Annu. Rev. Neurosci. 9, 489-512.
134. Ronda, A. C., Vasconsuelo, A., and Boland, R. (2010). Extracellular-regulated kinase and p38 mitogen-activated protein kinases are involved in the antiapoptotic action of 17beta-estradiol in skeletal muscle cells. J. Endocrinol. 206, 235-246.
135. Ronkainen, P. H., Kovanen, V., Alen, M., Pollanen, E., Palonen, E. M., Ankarberg-Lindgren, C., Hamalainen, E., Turpeinen, U., Kujala, U. M., Puolakka, J., Kaprio, J., and Sipila, S. (2009). Post-menopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs. J. Appl. Physiol. 107, 25-33.
136. Ronkainen, P. H., Pollanen, E., Alen, M., Pitkanen, R., Puolakka, J., Kujala, U. M., Kaprio, J., Sipila, S., and Kovanen, V. (2010). Global gene expression profiles in skeletal muscle of monozygotic female twins discordant for hormone replacement therapy. Aging Cell 9, 1098-1110.
137. Rose'Meyer, R. B., Mellick, A. S., Gar-nham, B. G., Harrison, G. J., Massa, H. M., and Griffiths, L. R. (2003). The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis. Brain Res. Brain Res. Protoc. 11, 9-18.
138. Rosenbaum, M., Nicolson, M., Hirsch, J., Heymsfield, S. B., Gallagher, D., Chu, F., and Leibel, R. L. (1996). Effects of gender, body composition, and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab. 81, 3424-3427.
139. Rossouw, J. E., Anderson, G. L., Prentice, R. L., Lacroix, A. Z., Kooper-berg, C., Stefanick, M. L., Jackson, R. D., Beresford, S. A., Howard, B. V., Johnson, K. C., Kotchen, J. M., and Ockene, J. (2002). Risks and benefits of estrogen plus prog-estin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
140. Roth, G. S. (1990). In Genetic Effects on Aging II. Caldwell, NY: Telford Press.
141. Roth, G. S., and Joseph, J. A. (1994). Cellular and molecular mechanisms of impaired dopaminergic function during aging. Ann. N. Y. Acad. Sci. 719, 129-135.
142. Rozenbaum, H. (2006). How to evaluate the risk-benefit ratio of the low-dose hormone replacement therapy? J. Steroid Biochem. Mol. Biol. 102, 256-260.
143. Saad, M. F., Damani, S., Gingerich, R. L., Riad-Gabriel, M. G., Khan, A., Boyadjian, R., Jinagouda, S. D., El-Tawil, K., Rude, R. K., and Kamdar,V. (1997). Sexual dimorphism in plasma leptin concentration. J. Clin. Endocrinol. Metab. 82, 579-584.
144. Schomburg, L., and Bauer, K. (1997). Regulation of the adenohypophy-seal thyrotropin-releasing hormone-degrading ectoenzyme by estradiol. Endocrinology 138, 3587-3593.
145. Shang, Y., and Brown, M. (2002). Molecular determinants for the tissue specificity of SERMs. Science 295, 2465-2468.
146. Shao, W., and Brown, M. (2004). Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res. 6, 39-52.
147. Shaw, T. J., and Martin, P. (2009). Wound repair at a glance. J. Cell Sci. 122, 3209-3213.
148. Shearman, A. M., Cooper, J. A., Kotwin-ski, P. J., Miller, G. J., Humphries, S. E., Ardlie, K. G., Jordan, B., Irenze, K., Lunetta, K. L., Schuit, S. C., Uitterlinden, A. G., Pols, H. A., Demissie, S., Cupples, L. A., Mendelsohn, M. E., Levy, D., and Hous-man, D. E. (2006). Estrogen receptor alpha gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circ. Res. 98, 590-592.
149. Shimizu, T. (2005). Role of macrophage migration inhibitory factor (MIF) in the skin. J. Dermatol. Sci. 37, 65-73.
150. Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1997). Comparative distribution of estrogen receptor-alpha and-beta mRNA in the rat central nervous system. J. Comp. Neurol. 388, 507-525.
151. Shughrue, P. J., and Merchenthaler, I. (2000). Evidence for novel estrogen binding sites in the rat hippocampus. Neuroscience 99, 605-612.
152. Silverman, S. L., Christiansen, C., Genant, H. K., Vukicevic, S., Zanchetta, J. R., De Villiers, T. J., Constantine, G. D., and Chines, A. A. (2008). Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial. J. Bone Miner. Res. 23, 1923-1934.
153. Simoncini, T., and Genazzani, A. R. (2000). Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J. Clin. Endocrinol. Metab. 85, 2966-2969.
154. Sinclair, R., Banfield, C., and Dawber, R. (1999). Handbook of Diseases of the Hair and the Scalp. New York: Blackwell, Oxford Press.
155. Singh, M., Meyer, E. M., Huang, F. S., Millard, W. J., and Simpkins, J. W. (1993). Ovariectomy reduces ChAT activity and NGF mRNA levels in the frontal cortex and hippocampus of the female Sprague-Dawley rat. Soc. Neurosci. Abstr. 19, 11.
156. Singh, M., Meyer, E. M., and Simpkins, J. W. (1995). The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136, 2320-2324.
157. Sipila, S., Taaffe, D. R., Cheng, S., Puo-lakka, J., Toivanen, J., and Suomi-nen, H. (2001). Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin. Sci. 101, 147-157.
158. Son, E. D., Lee, J. Y., Lee, S., Kim, M. S., Lee, B. G., Chang, I. S., and Chung, J. H. (2005). Topical application of 17beta-estradiol increases extracellular matrix protein synthesis by stimulating tgf-beta signaling in aged human skin in vivo. J. Invest. Dermatol. 124, 1149-1161.
159. Stevenson, S., and Thornton, J. (2007). Effect of estrogens on skin aging and the potential role of SERMs. Clin. Interv. Aging 2, 283-297.
160. Stone, D. J., Rozovsky, I., Morgan, T. E., Anderson, C. P., Hajian, H., and Finch, C. E. (1997). Astro-cytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp. Neurol. 143, 313-318.
161. Stone, D. J., Song, Y., Anderson, C. P., Krohn, K. K., Finch, C. E., and Rozovsky, I. (1998). Bidirectional transcription regulation of glial fib-rillary acidic protein by estradiol in vivo and in vitro. Endocrinology 139, 3202-3209.
162. Student, A. K., Hsu, R. Y., and Lane, M. D. (1980). Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J. Biol. Chem. 255, 4745-4750.
163. Surazynski, A., Jarzabek, K., Haczyn-ski, J., Laudanski, P., Palka, J., and Wolczynski, S. (2003). Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int. J. Mol. Med. 12, 803-809.
164. Takahashi, S., Kawashima, S., Seo, H., and Matsui, N. (1990). Age-related changes in growth hormone and prolactin messenger RNA levels in the rat. Endocrinol. Jpn. 37, 827-840.
165. Tashjian, A. H. Jr., Yasumura, Y., Levine, L., Sato, G. H., and Parker, M. L. (1968). Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82, 342-352.
166. Teede,H. J., Lombard, C., and Deeks, A. A. (2010). Obesity, metabolic complications and the menopause: an opportunity for prevention. Climacteric 13, 203-209.
167. Thakur, M. K., and Sharma, P. K. (2007). Transcription of estrogen receptor alpha and beta in mouse cerebral cortex: effect of age, sex, 17beta-estradiol and testosterone. Neurochem. Int. 50, 314-321.
168. Thornton, M. J. (2002). The biological actions of estrogens on skin. Exp. Dermatol. 11, 487-502.
169. Too, C. K., Giles, A., and Wilkinson, M. (1999). Estrogen stimulates expression of adenine nucleotide translocator ANT1 messenger RNA in female rat hearts. Mol. Cell. Endocrinol. 150, 161-167.
170. Tsukahara, K., Moriwaki, S., Ohuchi, A., Fujimura,T., and Takema,Y. (2001). Ovariectomy accelerates photoaging of rat skin. Photochem. Photobiol. 73, 525-531.
171. Tsukahara, K., Nakagawa, H., Moriwaki, S., Kakuo, S., Ohuchi, A., Takema, Y., and Imokawa, G. (2004). Ovariectomy is sufficient to accelerate spontaneous skin ageing and to stimulate ultraviolet irradiation-induced photoageing of murine skin. Br. J. Dermatol. 151, 984-994.
172. Vasconsuelo, A., Milanesi, L., and Boland, R. (2008). 17Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidyli-nositol 3-kinase/Akt pathway. J. Endocrinol. 196, 385-397.
173. Verdier-Sevrain, S., Bonte, F., and Gilchrest, B. (2006). Biology of estrogens in skin: implications for skin aging. Exp. Dermatol. 15, 83-94.
174. Wang, L. L., Qiu, G. R., Fu, W. N., Yuan, Z. W., and Sun, K. L. (2010). Transcriptional regulation of Fhl1 by estradiol in rat myoblastocytes. Steroids 75, 368-372.
175. Watters, J. J., and Dorsa, D. M. (1998). Transcriptional effects of estrogen on neuronal neurotensin gene expression involve cAMP/protein kinase A-dependent signaling mechanisms. J. Neurosci. 18, 6672-6680.
176. White, P. C., Rogoff, D., and Mcmillan, D. R. (2008). Physiological roles of 11 beta-hydroxysteroid dehydroge-nase type 1 and hexose-6-phosphate dehydrogenase. Curr. Opin. Pediatr. 20, 453-457.
177. Wiik, A., Ekman, M., Johansson, O., Jansson, E., and Esbjornsson, M. (2009a). Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. His-tochem. Cell Biol. 131, 181-189.
178. Wiik, A., Hellsten, Y., Berthelson, P., Lundholm, L., Fischer, H., and Jansson, E. (2009b). Activation of estrogen response elements is mediated both via estrogen and muscle contractions in rat skeletal muscle myotubes. Am. J. Physiol. Cell Physiol. 296, C215-220.
179. Wiik, A., Glenmark, B., Ekman, M., Esbjornsson-Liljedahl, M., Johansson, O., Bodin, K., Enmark, E., and Jansson, E. (2003). Oestrogen receptor beta is expressed in adult human skeletal muscle both at the mRNA and protein level. Acta Physiol. Scand. 179, 381-387.
180. Wilbur, J., Miller, A. M., Montgomery, A., and Chandler, P. (1998). Sociode-mographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 5, 43-51.
181. Wilson, M. E., Rosewell, K. L., Kashon, M. L., Shughrue, P. J., Merchen-thaler, I., and Wise, P. M. (2002). Age differentially influences estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) gene expression in specific regions of the rat brain. Mech. Ageing Dev. 123, 593-601.
182. Windahl, S. H., Andersson, G., and Gustafsson, J. A. (2002). Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol. Metab. 13, 195-200.
183. Yi, K. W., Shin, J. H., Seo, H. S., Lee, J. K., Oh, M. J., Kim, T., Saw, H. S., Kim, S. H., and Hur, J. Y. (2008). Role of estrogen receptor-alpha and-beta in regulating leptin expression in 3T3-L1 adipocytes. Obesity 16, 2393-2399.
184. Yoneda, N., Saito, S., Kimura, M., Yamada, M., Iida, M., Murakami, T., Irahara, M., Shima, K., and Aono, T. (1998). The influence of ovariec-tomy on ob gene expression in rats. Horm. Metab. Res. 30, 263-265.
185. Zallone, A. (2006). Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. N. Y. Acad. Sci. 1068, 173-179.
186. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
187. Zhou, S., Turgeman, G., Harris, S. E., Leitman, D. C., Komm, B. S., Bodine, P. V., and Gazit, D. (2003). Estrogens activate bone morpho-genetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol. Endocrinol. 17, 56-66.
188. Zhou, Y., Watters, J. J., and Dorsa, D. M. (1996). Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137, 2163-2166.
189. Zhu, Y., Bian, Z., Lu, P., Karas, R. H., Bao, L., Cox, D., Hodgin, J., Shaul, P. W., Thoren, P., Smithies, O., Gustafsson, J. A., and Mendelsohn, M. E. (2002). Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295, 505-508.
190. Zwart, W., Theodorou, V., and Carroll, J. S. (2011). Estrogen receptor-positive breast cancer: a multidisciplinary challenge. Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 216-230.